Current incidence of retinopathy of prematurity, 1989-1997.
about
Association of genetic polymorphisms of vascular endothelial growth factor and risk for proliferative retinopathy of prematurity.Results of screening for retinopathy of prematurity in a large nursery in Kuwait: Incidence and risk factorsInfection, oxygen, and immaturity: interacting risk factors for retinopathy of prematurity.The incidence and risk factors of severe retinopathy of prematurity in extremely low birth weight infants in Turkey.Retinopathy of prematurity in infants born before 25 weeks gestation in a Korean single neonatal intensive care unit: incidence, natural history and risk factorsRetinopathy of prematurity and pulse oximetry: a national survey of recent practices.Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP): four-years of screening with telemedicine.Retinopathy of prematurity: recent advances in our understanding.Evaluating retinopathy of prematurity screening guidelines for 24- to 27-week gestational age infantsPlacenta microbiology and histology and the risk for severe retinopathy of prematurity.Threshold retinopathy at threshold of viability: the EpiBel study.Importance of birth weight as a risk factor for severe retinopathy of prematurity when gestational age is 30 or more weeks.Adequacy of published screening criteria for retinopathy of prematurity.Role of Serum Levels of Vascular Endothelial Growth Factor and Its Receptor in Retinopathy of PrematurityThe prevalence and risk factors of retinopathy of prematurity among preterm babies admitted to Soba Neonatal Intensive Care Unit.The 'ideal' management of retinopathy of prematurity.Endothelial nitric oxide synthase gene T-786C and 27-bp repeat gene polymorphisms in retinopathy of prematurity.Incidence of retinopathy of prematurity requiring treatment in infants born greater than 30 weeks' gestation and with a birthweight greater than 1250 g from 1998 to 2002: a regional study.Infantile hemangiomas and retinopathy of prematurity: clues to the regulation of vasculogenesis.Matrix metalloproteinases and their tissue inhibitors in preterm perinatal complications.Changes in Course of Retinopathy of Prematurity from 1986 to 2013: Comparison of Three Studies in the United States.Incidence and risk factors of retinopathy of prematurity in mashhad, northeast iranA novel model of retinopathy of prematurity in normobaric hyperoxic conditionsStudy protocol: safety and efficacy of propranolol 0.2% eye drops in newborns with a precocious stage of retinopathy of prematurity (DROP-ROP-0.2%): a multicenter, open-label, single arm, phase II trial.Mode of delivery and threshold retinopathy of prematurity in pre-term ELBW neonates.Retinopathy of prematurity in port harcourt, NigeriaCumulative illness severity and progression from moderate to severe retinopathy of prematurity.Incidence and risk factors for retinopathy of prematurity in very low and in extremely low birth weight infants in a unit-based approach in southern Brazil.Fungal and bacterial sepsis and threshold ROP in preterm very low birth weight neonates.Early pituitary-adrenal responses and retinopathy of prematurity in very low birth weight infants.Assessment of WINROP algorithm as screening tool for preterm infants in Manitoba to detect retinopathy of prematurity.
P2860
Q33210617-1E5705FD-2909-47A8-A95D-AEFEE2FCFF90Q33562732-16355EA7-3A3F-442A-8115-F20D376645FFQ34130329-E1D5E1B5-27E2-4AA8-B72D-012D07BBD898Q34229923-8433D1C3-344D-4AD1-9903-824B73D3ECCDQ34518812-EA4829B7-22FE-48D1-BFE9-4CAF427654E8Q34546090-3C3EE41E-333A-46BA-9F20-A442361A0227Q34553717-E81A1DEB-D574-4900-80C0-0E5D5550B069Q34659611-A033C341-99D5-46BA-9A01-77CDE06DCD51Q35087725-5CCBCA7B-0558-4470-A301-3557DCFC0E12Q35518931-A55FC0AD-DB29-4881-BBBC-E6061D39AE57Q35591750-6896D9F8-C96D-4616-A1CE-4B4698C6FD95Q35601642-EA665827-DC57-4E59-B151-B63D80563F95Q35739541-B07C5BF1-E023-45A0-BC63-F02E5A069AF5Q36074918-6EBAB71C-DC0F-452B-BE90-F732DB2C83A3Q36095653-908D33BA-4973-455D-8E01-4F2971B9593CQ36320396-0C199C74-8F0C-40BD-BB45-99C797ACEF20Q36489211-1A6C4349-9404-4870-87ED-A50F572F5D54Q36493716-735BA06E-1452-4EB6-BCE5-5206E315BB98Q36875692-F4FD7FC0-B44F-4FC9-ABB2-B5984C6A5E2DQ37000242-835A4E5B-4B64-40CA-B1DC-A030DB7637B7Q37038705-3E8CCF0C-A5F6-48E4-B678-634C60CCE71CQ37100690-E2136F92-2704-4309-9811-5D899C8EC75BQ37266875-9B3F778A-53C3-46AC-8324-2179FF520965Q38373964-BBB2F59C-152C-48C6-B535-801A87CF2F1BQ39793434-B2D9B256-AA14-4A05-9794-5EAD6322FDF5Q41972629-F99640F3-4114-4A3A-B826-31B66E392FE2Q43478218-47AEFCF8-23D0-463C-A084-882A5711F5FAQ43690135-E6C62602-EB01-419F-86F1-DD166F28FFF3Q44569603-785A4970-CD3A-4467-9C56-1216C4EDAB4FQ44647123-8CD83060-3681-4FF3-800D-2A022ACE0E1EQ55355197-1437023F-9E81-4483-A176-7D38CFF874EE
P2860
Current incidence of retinopathy of prematurity, 1989-1997.
description
1999 nî lūn-bûn
@nan
1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Current incidence of retinopathy of prematurity, 1989-1997.
@ast
Current incidence of retinopathy of prematurity, 1989-1997.
@en
type
label
Current incidence of retinopathy of prematurity, 1989-1997.
@ast
Current incidence of retinopathy of prematurity, 1989-1997.
@en
prefLabel
Current incidence of retinopathy of prematurity, 1989-1997.
@ast
Current incidence of retinopathy of prematurity, 1989-1997.
@en
P2093
P356
P1433
P1476
Current incidence of retinopathy of prematurity, 1989-1997.
@en
P2093
P356
10.1542/PEDS.104.3.E26
P407
P577
1999-09-01T00:00:00Z